Program cuts outpatient antibiotic RX for pediatric respiratory infections

Program cuts outpatient antibiotic rx for peds respiratory infections

(HealthDay)—A distance learning program is effective for reducing outpatient prescribing for pediatric acute respiratory tract infection (ARTI) visits, according to a study published online Aug. 3 in Pediatrics.

Matthew P. Kronman, M.D., from the University of Washington in Seattle, and colleagues examined a distance learning program's effectiveness for reducing outpatient antibiotic prescribing for ARTI visits. During 11 months, clinicians received the intervention as three program modules containing and webinars on evidence-based and antibiotic prescribing, booster video vignettes, and individualized antibiotic prescribing feedback reports.

The researchers observed a 7 percent decrease in the probability of antibiotic prescribing for ARTI overall between the baseline and postintervention periods (adjusted rate ratio [aRR], 0.93; 95 percent confidence interval [CI], 0.90 to 0.96) among 72,723 ARTI visits by 29,762 patients. There were decreases in second-line antibiotic prescribing for and sinusitis (aRRs, 0.66 [95 percent CI, 0.50 to 0.87] and 0.59 [95 percent CI, 0.44 to 0.77], respectively), but not for acute otitis media (aRR, 0.93; 95 percent CI, 0.83 to 1.03). Decreases were seen in any antibiotic prescribing for viral ARTIs (aRR, 0.60; 95 percent CI, 0.51 to 0.70).

"Providing online communication training and evidence-based antibiotic prescribing education in combination with individualized antibiotic prescribing feedback reports may help achieve national goals of reducing unnecessary outpatient for children," the authors write.

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Journal information: Pediatrics

Copyright © 2020 HealthDay. All rights reserved.

Citation: Program cuts outpatient antibiotic RX for pediatric respiratory infections (2020, August 4) retrieved 1 October 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments